Literature DB >> 8262948

Genetic and biochemical studies of bacteriophage T4 DNA polymerase 3'-->5'-exonuclease activity.

L J Reha-Krantz1, R L Nonay.   

Abstract

DNA polymerase exonucleolytic proofreading is important in attaining high fidelity DNA replication. One of the most well characterized proofreading activities is the 3'-->5'-exonuclease activity of bacteriophage T4 DNA polymerase. We have used genetic analyses and protein sequence comparisons to Escherichia coli DNA polymerase I to identify amino acids in the N-terminal region of T4 DNA polymerase that are required for exonucleolytic proofreading. Mutant DNA polymerases with amino acid substitutions D112A/E114A, D219A, or D324A reduced 3'-->5'-exonuclease activity 10(2)-10(4)-fold in various in vitro assays and decreased DNA replication fidelity in vivo. DNA replication activity was also reduced for the exonuclease-deficient DNA polymerases in vitro and in vivo. Reduction in DNA replication appeared to be due primarily to the interdependence of T4 DNA polymerase replication and proofreading activities; T4 DNA polymerase requires 3'-->5'-exonuclease activity to repair primer termini that are not suitable substrates for extension. Observations reported here provide further evidence in support of the proposal that DNA polymerases have distinct 3'-->5'-exonuclease and polymerase active sites.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8262948

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  25 in total

Review 1.  DNA replication fidelity in Escherichia coli: a multi-DNA polymerase affair.

Authors:  Iwona J Fijalkowska; Roel M Schaaper; Piotr Jonczyk
Journal:  FEMS Microbiol Rev       Date:  2012-04-05       Impact factor: 16.408

2.  Differences in replication of a DNA template containing an ethyl phosphotriester by T4 DNA polymerase and Escherichia coli DNA polymerase I.

Authors:  Laura Tsujikawa; Michael Weinfield; Linda J Reha-Krantz
Journal:  Nucleic Acids Res       Date:  2003-09-01       Impact factor: 16.971

3.  Dynamics of nucleotide incorporation: snapshots revealed by 2-aminopurine fluorescence studies.

Authors:  Chithra Hariharan; Linda B Bloom; Sandra A Helquist; Eric T Kool; Linda J Reha-Krantz
Journal:  Biochemistry       Date:  2006-03-07       Impact factor: 3.162

4.  Double-strand break repair in bacteriophage T4: recombination effects of 3'-5' exonuclease mutations.

Authors:  Victor P Shcherbakov; E A Kudryashova; T S Shcherbakova; S T Sizova; L A Plugina
Journal:  Genetics       Date:  2006-10-08       Impact factor: 4.562

5.  3' to 5' exonuclease activity of herpes simplex virus type 1 DNA polymerase modulates its strand displacement activity.

Authors:  Yali Zhu; Kelly S Trego; Liping Song; Deborah S Parris
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

6.  Proofreading-defective DNA polymerase II increases adaptive mutation in Escherichia coli.

Authors:  P L Foster; G Gudmundsson; J M Trimarchi; H Cai; M F Goodman
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

7.  Identification of a transient excision intermediate at the crossroads between DNA polymerase extension and proofreading pathways.

Authors:  R P Baker; L J Reha-Krantz
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

Review 8.  Regulation of DNA polymerase exonucleolytic proofreading activity: studies of bacteriophage T4 "antimutator" DNA polymerases.

Authors:  L J Reha-Krantz
Journal:  Genetics       Date:  1998-04       Impact factor: 4.562

9.  Effects of mutations in the Exo III motif of the herpes simplex virus DNA polymerase gene on enzyme activities, viral replication, and replication fidelity.

Authors:  Y T Hwang; B Y Liu; D M Coen; C B Hwang
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 10.  Bacteriophage T4 genome.

Authors:  Eric S Miller; Elizabeth Kutter; Gisela Mosig; Fumio Arisaka; Takashi Kunisawa; Wolfgang Rüger
Journal:  Microbiol Mol Biol Rev       Date:  2003-03       Impact factor: 11.056

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.